Biohaven Pharmaceutical Holding Co (BHVN) insider buying

Healthcare · Biotechnology · Market cap $1.8B

4 open-market purchases of BHVN by Biohaven Pharmaceutical Holding Co's executives and directors since November 2025, worth $33M in total, from SEC Form 4 filings.

The most recent: George C Clark bought $144,840 on November 17, 2025.

The biggest buyer over the period is John W Childs: 1 purchase, $25M.

By year

YearPurchasesValue
20254$33M

Biggest buyers

InsiderBuysValue
John W Childs
1$25M
Vlad Coric
1$5M
Gregory Bailey
1$3M
George C Clark
1$144,840

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Nov 17, 2025 George C Clark
 17,000$8.52$144,840 Form 4
Nov 13, 2025 Gregory Bailey
 400,000$7.50$3M Form 4
Nov 13, 2025 John W Childs
 3,333,333$7.50$25M Form 4
Nov 13, 2025 Vlad Coric
 666,666$7.50$5M Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BHVN.
Open BHVN in Investingly

Questions

Are Biohaven Pharmaceutical Holding Co insiders buying the stock?

4 open-market purchases of BHVN by Biohaven Pharmaceutical Holding Co's executives and directors since November 2025, worth $33M in total, from SEC Form 4 filings. The most recent: George C Clark bought $144,840 on November 17, 2025.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Biohaven Pharmaceutical Holding Co's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.